Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jun 28–Jul 5, 2026)

· 1 min read

Here’s what’s on the biotech calendar for June 28–July 5: 2 FDA decision dates, 15 trial catalysts, and 0 earnings reports from tracked companies.

💊 FDA Decisions (PDUFA Dates)

Date Ticker Drug Indication Type
2026-06-29 UNCY — hyperphosphatemia in patients NDA
2026-06-30 VRDN — patients with TED BLA

📡 Run-up Radar Highlights

Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature):

  • CELC: NDA in 19 days, score 79/100
  • VERA: BLA in 9 days, score 79/100
  • UNCY: NDA in 1 days, score 79/100

📈 Last Week’s Biggest Gainers

  • APGE +46.66% (volume 32.0x average)
  • TECH +20.08% (volume 18.8x average)

Track your tickers on the BioRadar dashboard →

This digest is for informational purposes only and is not investment advice. Always do your own research.

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.